The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions

Research output: Contribution to journalJournal articleResearchpeer-review

  • R Elias Alvarado
  • Filip Oskar Mundt
  • Richard Lindqvist
  • Josephine Kerzel Duel
  • Fabian Coscia
  • Emma Nilsson
  • Kumari Lokugamage
  • Bryan A Johnson
  • Jessica A Plante
  • Dorothea R Morris
  • Michelle N Vu
  • Leah K Estes
  • Alyssa M McLeland
  • Jordyn Walker
  • Patricia A Crocquet-Valdes
  • Blanca Lopez Mendez
  • Kenneth S Plante
  • David H Walker
  • Anna K Överby
  • Vineet D Menachery

Viruses interact with numerous host factors to facilitate viral replication and to dampen antiviral defense mechanisms. We currently have a limited mechanistic understanding of how SARS-CoV-2 binds host factors and the functional role of these interactions. Here, we uncover a novel interaction between the viral NSP3 protein and the fragile X mental retardation proteins (FMRPs: FMR1, FXR1-2). SARS-CoV-2 NSP3 mutant viruses preventing FMRP binding have attenuated replication in vitro and reduced levels of viral antigen in lungs during the early stages of infection. We show that a unique peptide motif in NSP3 binds directly to the two central KH domains of FMRPs and that this interaction is disrupted by the I304N mutation found in a patient with fragile X syndrome. NSP3 binding to FMRPs disrupts their interaction with the stress granule component UBAP2L through direct competition with a peptide motif in UBAP2L to prevent FMRP incorporation into stress granules. Collectively, our results provide novel insight into how SARS-CoV-2 hijacks host cell proteins and provides molecular insight into the possible underlying molecular defects in fragile X syndrome.

Original languageEnglish
JournalEMBO Reports
ISSN1469-221X
DOIs
Publication statusPublished - 2024

Bibliographical note

© 2024. The Author(s).

ID: 378869365